Kinoshita Kosho, Ashenagar Mohammad Said, Tabuchi Masaki, Higashino Hideaki
Department of Pharmacology, Kinki University School of Medicine, Osaka 589-8511, Japan.
Exp Ther Med. 2011 Mar;2(2):201-212. doi: 10.3892/etm.2011.193. Epub 2011 Jan 14.
Clarification of the genetic nature and more effective care for hypertension are required, given the high incidences of cardiovascular and cerebrovascular mortality. Thus, we surveyed candidate genes for hypertension with rat whole gene DNA microarrays using three novel methods. Gene expression analyses were conducted as follows: Method 1, three types of spontaneously hypertensive rat (SHR) substrains, SHR, stroke-prone SHR (SHRSP) and malignant type of SHRSP (M-SHRSP) were used and compared to normotensive Wistar Kyoto rats; Method 2, the expressed genes between rats of different ages were compared for different blood pressures; and Method 3, genes that were expressed in rats treated with or without an acute hypotensive stimulus, the antihypertensive hydralazine hydrochloride, were compared. This approach identified dozens of genes, including Dusp15, Cyp8b1, Armc 3, Gtpbp4, Mettl2, Mapk14, Prkar2b, frame 12, Anxa13, Ephx2, Myr8 and Pcdh9 by Method 1; Cyp2C and Atp12a by Method 2; and Kcnc3, Vnn1, TC560558 and Gabrq and a number of unknown genes by Methods 2 and 3, as probable candidate genes for hypertension in SHR substrains. Ephx2 was previously reported as a candidate gene in SHRs; however other genes were identified for the first time in this study. Since it was not always possible to completely demonstrate that these genes are responsible for hypertension in SHRs, further research into true candidate genes that participate in the genesis of hypertension in SHR substrains is warranted.
鉴于心血管和脑血管疾病的高死亡率,有必要明确高血压的遗传本质并提供更有效的治疗。因此,我们使用三种新方法,通过大鼠全基因DNA微阵列对高血压候选基因进行了研究。基因表达分析如下:方法1,使用三种自发性高血压大鼠(SHR)亚系,即SHR、易中风SHR(SHRSP)和恶性型SHRSP(M-SHRSP),并与血压正常的Wistar Kyoto大鼠进行比较;方法2,比较不同年龄、不同血压大鼠之间的表达基因;方法3,比较给予或未给予急性降压刺激(降压药盐酸肼屈嗪)的大鼠中表达的基因。该方法确定了数十个基因,方法1确定的有Dusp15、Cyp8b1、Armc 3、Gtpbp4、Mettl2、Mapk14、Prkar2b、框架12、Anxa13、Ephx2、Myr8和Pcdh9;方法2确定的有Cyp2C和Atp12a;方法2和3确定的有Kcnc3、Vnn1、TC560558和Gabrq以及一些未知基因,这些基因可能是SHR亚系高血压的候选基因。Ephx2此前已被报道为SHR中的候选基因;然而,其他基因是本研究首次鉴定出来的。由于并非总能完全证明这些基因与SHR的高血压有关,因此有必要进一步研究参与SHR亚系高血压发生的真正候选基因。